Allied Corp.

ALID

US0191141078

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 12:24:55 2026-01-16 pm EST			5-day change	1st Jan Change
0.0111 ^USD	-.--%		-.--%	+2,120.00%

Jan. 26	Mali takes 51% stake in China-backed local explosives venture	RE
25-02-05	Allied Corp. Announces Resignation of Calum Hughes as Chief Executive Officer	CI

Allied Corp. Announces Resignation of Santiago Ribero as Director

Published on 03/29/2024 at 08:08 am EDT

S&P Capital IQ

ALLIED CORP.

-.--%

Allied Corp. announced that effective March 20, 2024 Santiago Ribero resigned as a Director of the company Mr. Ribero has moved to the United States and has taken a position in the banking industry, but will continue to have an active role with the Company.

Latest news about Allied Corp.

Jan. 26	Mali takes 51% stake in China-backed local explosives venture	RE
25-02-05	Allied Corp. Announces Resignation of Calum Hughes as Chief Executive Officer	CI
25-02-05	Allied Corp. Announces Resignation of Calum Hughes as Director	CI
25-01-14	Allied Corp. Reports Earnings Results for the First Quarter Ended November 30, 2024	CI
24-12-16	Allied Corp. Reports Earnings Results for the Full Year Ended August 31, 2024	CI
24-12-15	Allied Corp. Auditor Raises 'Going Concern' Doubt	CI
24-11-18	Allied Corp. Completes 30Kg Shipment to Portuguese Channel Partner, Initiating United Kingdom Supply Contract	CI
24-10-16	Allied Colombia S.A.S. Enters into Forward Purchase Agreement with CanPoland Spolka Akeyina and Blossom Genetics Lda	CI
24-09-13	Allied Corp. Announces the Cessation of Ryan Maarschalk as Chief Financial Officer	CI
24-08-07	Allied Corp. announced that it has received $0.5 million in funding	CI
24-07-18	Allied Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2024	CI
24-07-01	Allied Corp Successfully Ships 180Kg of Medical Cannabis Fulfilling Purchase Order, Buyer Granted Additional Import Permits	CI
24-04-19	Allied Corp. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	CI
24-04-09	Allied Corp. announced that it expects to receive $0.6 million in funding	CI
24-03-29	Allied Corp. Announces Resignation of Santiago Ribero as Director	CI

Chart Allied Corp.

Duration

Period

ALID: Dynamic Chart

Company Profile

Allied Corp. is a Canadian cannabis supplier with its production center in Colombia. It is focused on the development of Colombian produced medicinal cannabis for patients with conditions potentially suitable for treatment. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder, Parkinson's disease, Tourette's syndrome, irritable bowel syndrome and spasticity associated with multiple sclerosis and spinal cord injury. Its core hemp derived cannabidiol (CBD) brands are Tactical Relief Brand, Equilibrium Bio and MaXXa. Liberty, Tactical Relief brand's flagship product, is a hemp derived CBD tincture for sale in the United States. Equilibrium Bio brand is primarily focused on hydration and recovery areas. MaXXa brand develops natural CBD infused cosmetics and beauty products. Its subsidiaries include AM Biosciences, Allied US Products LLC, Tactical Relief LLC, Baleno Ltd. and Allied Colombia.

Employees

Sector

Pharmaceuticals

Calendar

Jan. 18 - Q1 2027 Earnings Release (Projected)

More about the company